Opioid Receptors



20 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A14085

Eluxadoline

opioid receptor agonist
Eluxadoline is a novel, orally-active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D).
A15444 SALE

TRV130 HCl (Oliceridine)

µ- opioid receptor agonist
TRV 130 HCl is a novel μ-opioid receptor (MOR) G protein-biased ligand; elicits robust G protein signaling(pEC50=8.1), with potency and efficacy similar to morphine, but with far less beta-arrestin recruitment and receptor internalization.
A15149

LY2795050

k-opioid receptor antagonist
LY2795050 is a novel selective ??-opioid Receptor (KOR) antagonist (IC50=0.72 nM) and has the potential as a PET tracer to image KOR in vivo.
A15159

Methylnaltrexone Bromide

μ-opioid antagonist
Methylnaltrexone Bromide is a pheriphally-acting ??-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.
A11072 SALE

ADL5859 HCl

Opioid Receptor agonist
ADL5859 HCl is a highly potent and selective δ opioid receptor agonist with Ki value to be 0.84 nM and ED50 value to be 20 nM.
A13479

ADL5747

δ opioid receptor agonist
ADL5747 is a selective, nonpeptidic δ opioid receptor agonist.
A14991

Alvimopan dihydrate

µ-opioid receptor agonist
Alvimopan dihydrate(LY 246736, ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
A14992

Alvimopan monohydrate

µ-opioid receptor agonist
Alvimopan monohydrate is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
A15972

Naloxegol Oxalate

Opioid antagonist
Naloxegol is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.
A14337

TRV130 (Oliceridine)

μ-opioid receptor agonist
TRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less ??-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.
A14187

U-69593

κ1-opioid receptor agonist
U-69593 is a potent, selective κ1-opioid receptor agonist (EC50 = 80-109 nM). Active in vivo. Antinociceptive.
A11076 SALE

JTC-801

Opioid Receptor antagonist
JTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.
A10561 SALE

MCOPPB 3HCl

NOP receptor agonist
MCOPPB is a compound which acts as a potent and selective agonist for the nociceptin receptor, with a pKi of 10.07.
A11210

BRL 52537 HCl

Opioid Receptors agonist
BRL 52537 hydrochloride is a highly selective and potent κ-opioid agonist (Ki = 0.24 nM). 25 times more potent than morphine.
A11292 SALE

Alvimopan (ADL 8-2698)

Opioid antagonist
Alvimopan behaves as a peripherally acting μ-opioid antagonist. Alvimopan competitively binds to mu-opioid receptor in the gastrointestinal tract.
A11322

BAN ORL 24

NOP antagonist
BAN ORL 24 is a potent and selective NOP receptor antagonist.
A11718 SALE

Trimebutine

-
Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.
A12579 SALE

Nalfurafine hydrochloride

opioid κ-selective agonist
Nalfurafine hydrochloride is a kappa-opioid receptor agonist
A13843 SALE

Nalmefene hydrochloride

dopamine receptor agonist
Nalmefene hydrochloride is an opioid receptor antagonist.
A16155

Docusate Sodium

-
Docusate Sodium is a laxative used to treat constipation, for constipation due to the use of opiates it maybe used with a stimulant laxative, can be taken by mouth or rectally.

20 Item(s)

per page

Set Descending Direction